Eudald Felip - Publications

Modulation of IRF7-driven transcription as a strategy to control HIV-1 latency.

Journal: Frontiers in immunology

Published: October 29, 2025

Immune-based transcriptomic signature predicts CDK4/6 inhibitor efficacy in HR+/HER2- breast cancer.

Journal: Clinical and translational medicine

Published: May 20, 2025

Molecular Landscape, Genomic Shift, and Prediction in the Neoadjuvant Setting of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: February 05, 2025

Assessing the Prognostic Value of Cytoplasmic and Stromal Caveolin-1 in Early Triple-Negative Breast Cancer Undergoing Neoadjuvant Chemotherapy.

Journal: International journal of molecular sciences

Published: September 17, 2024

Deciphering HER2-low breast cancer (BC): insights from real-world data in early stage breast cancer.

Journal: Therapeutic advances in medical oncology

Published: July 13, 2024

Elderly patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors in a multicentre cohort.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: October 17, 2023

SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: August 07, 2023

Pre- and Post-Neoadjuvant Clinicopathological Parameters Can Help in the Prognosis and the Prediction of Response in HER2+ and Triple Negative Breast Cancer.

Journal: Cancers

Published: April 13, 2023

Validation of a prognostic model for predicting larynx preservation outcome (TALK score) in a Southern European population.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: December 30, 2022

Immune Response and Effects of COVID-19 Vaccination in Patients with Lung Cancer-COVID Lung Vaccine Study.

Journal: Cancers

Published: December 06, 2022

SAMHD1 expression modulates innate immune activation and correlates with ovarian cancer prognosis.

Journal: Frontiers in immunology

Published: November 30, 2022

Pharmacological Inhibition of IKK to Tackle Latency and Hyperinflammation in Chronic HIV-1 Infection.

Journal: International journal of molecular sciences

Published: November 02, 2022